Antiola, Mark A.

HRN: 27-85-87  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2025
CEFTRIAXONE 1G (VIAL)
09/27/2025
10/04/2025
IV
2g
Q24
Capmr
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines